Contracts with the DIVAT biobank DIVAT/Centaure (DHOS/Inserm 2008)
| | Investigators | GIRAL M, BROUARD S. (UMR643) | Study
| "One year validation of chronic rejection BIOMARKERS."* |
La Charité Berlin
| | Investigators | GIRAL M, DRAGUN D. (Berlin, Germany)
| | Study | "Anti angiotensin II type I receptor and anti endothelin* and risk of acute rejection episode."
| Institut de Recherche en Immunologie et Hématologie EA3948. Strasbourg
| | Investigators | BAHRAM S, CARAPITO R. (Strasbourg, France)
| | Study | "Genotype MICA and anti-MICA in incident patients since 1998."
|
GSK Laboratory
| | Investigators | GIRAL M. (Nantes)
| | Study | "Baff dosage in highly stable patients."
| RISET Network (FP6)
| | Investigators | BROUARD S. (Nantes)
| | Study | "IP10 dosage in highly stable patients."
| P. Halloran, (Edmonton, Canada)
| | Investigators | RENAUDIN K. (Nantes)
| | Study | "One year Kidney biopsies and correlation with chronic rejection biomarkers."
| M. Daha (Leiden university) / V. Fremeaux Bacchi (CHU pompidou)
| | Investigators | GOSSELIN M. (Nantes)
| | Study | "Complement analysis on Kidney biopsies with antibody mediated rejection."
| DIVAT/Centaure network
| | Investigators | GIRAL M, BROUARD S. (UMR643)
| | Study | "CENTAURE 2010 (PAC 4) Validation of chronic rejection biomarker in “for cause” biopsies."
| * Publications: published or submitted
|
Scientific projects